CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+5.68%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$4.78B
AUM Growth
–
Cap. Flow
+$4.74B
Cap. Flow
% of AUM
99.08%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
616
New
605
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$84.5M |
| 2 |
Gilead Sciences
GILD
|
+$83.7M |
| 3 |
Apple
AAPL
|
+$79.3M |
| 4 |
Qualcomm
QCOM
|
+$74.7M |
| 5 |
Amgen
AMGN
|
+$73M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 24.38% |
| 2 | Financials | 14.02% |
| 3 | Technology | 12.71% |
| 4 | Industrials | 8% |
| 5 | Energy | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LXFT
201
DELISTED
Luxoft Holding, Inc.
LXFT
| $6.06M | 0.13% |
+157,475
| New | +$6.06M |
|
202
TG Therapeutics
TGTX
$5.08B
| $6.02M | 0.13% |
+380,000
| New | +$6.02M |
|
|
SWN
203
DELISTED
Southwestern Energy Company
SWN
| $6.01M | 0.13% |
+220,270
| New | +$6.01M |
|
204
Bio-Techne
TECH
$8.43B
| $5.82M | 0.12% |
+252,000
| New | +$5.82M |
|
205
East-West Bancorp
EWBC
$14.9B
| $5.81M | 0.12% |
+150,000
| New | +$5.81M |
|
206
Amicus Therapeutics
FOLD
$2.43B
| $5.78M | 0.12% |
+695,000
| New | +$5.78M |
|
207
Akamai
AKAM
$11.2B
| $5.77M | 0.12% |
+91,678
| New | +$5.77M |
|
208
Fifth Third Bancorp
FITB
$30.1B
| $5.77M | 0.12% |
+283,250
| New | +$5.77M |
|
209
McKesson
MCK
$87.8B
| $5.74M | 0.12% |
+27,649
| New | +$5.74M |
|
210
Union Pacific
UNP
$128B
| $5.73M | 0.12% |
+48,130
| New | +$5.73M |
|
211
3M
MMM
$81.5B
| $5.69M | 0.12% |
+41,434
| New | +$5.69M |
|
212
Kinross Gold
KGC
$27.3B
| $5.67M | 0.12% |
+2,014,228
| New | +$5.67M |
|
|
FDO
213
DELISTED
FAMILY DOLLAR STORES
FDO
| $5.66M | 0.12% |
+71,500
| New | +$5.66M |
|
|
KERX
214
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $5.52M | 0.12% |
+390,000
| New | +$5.52M |
|
|
ICPT
215
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.46M | 0.11% |
+35,000
| New | +$5.46M |
|
216
McDonald's
MCD
$223B
| $5.45M | 0.11% |
+58,152
| New | +$5.45M |
|
217
Capri Holdings
CPRI
$2.54B
| $5.34M | 0.11% |
+71,129
| New | +$5.34M |
|
|
MON
218
DELISTED
Monsanto Co
MON
| $5.31M | 0.11% |
+44,422
| New | +$5.31M |
|
219
Acadia Pharmaceuticals
ACAD
$4.19B
| $5.24M | 0.11% |
+165,000
| New | +$5.24M |
|
|
TIF
220
DELISTED
Tiffany & Co.
TIF
| $5.24M | 0.11% |
+48,987
| New | +$5.24M |
|
221
CVS Health
CVS
$91B
| $5.2M | 0.11% |
+54,030
| New | +$5.2M |
|
222
PTC Therapeutics
PTCT
$4.64B
| $5.18M | 0.11% |
+100,000
| New | +$5.18M |
|
223
Brown-Forman Class B
BF.B
$13B
| $5.08M | 0.11% |
+180,766
| New | +$5.08M |
|
224
Honeywell
HON
$136B
| $5.08M | 0.11% |
+53,321
| New | +$5.08M |
|
|
TSRO
225
DELISTED
TESARO, Inc.
TSRO
| $5.06M | 0.11% |
+136,000
| New | +$5.06M |
|